GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (FRA:6MD) » Definitions » Gross-Profit-to-Asset %

Medacta Group (FRA:6MD) Gross-Profit-to-Asset % : 51.32% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Medacta Group's annualized Gross Profit for the quarter that ended in Dec. 2023 was €344.0 Mil. Medacta Group's average Total Assets over the quarter that ended in Dec. 2023 was €670.2 Mil. Therefore, Medacta Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 51.32%.


Medacta Group Gross-Profit-to-Asset % Historical Data

The historical data trend for Medacta Group's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Gross-Profit-to-Asset % Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only 57.49 50.15 56.11 56.86 54.34

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.02 57.07 55.27 57.23 51.32

Competitive Comparison of Medacta Group's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Medacta Group's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Medacta Group's Gross-Profit-to-Asset % falls into.



Medacta Group Gross-Profit-to-Asset % Calculation

Medacta Group's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=347.847/( (584.488+695.871)/ 2 )
=347.847/640.1795
=54.34 %

Medacta Group's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=343.962/( (644.626+695.871)/ 2 )
=343.962/670.2485
=51.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Medacta Group Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Medacta Group's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (FRA:6MD) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.

Medacta Group (FRA:6MD) Headlines

No Headlines